Century Therapeutics, Inc.

Healthcare · Biotechnology · United States

Last price 1.47 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 266.18M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Century Therapeutics, Inc., a biotechnology company, engages in the development of allogeneic cell therapies for the treatment of solid tumor, hematological malignancies, and autoimmune diseases. Its lead product candidate is CNTY-813, an iPSC-derived beta islet cell replacement therapy engineered with Allo-Evasion 5.0 for the treatment of type 1 diabetes. The company is also involved in the development of CNTY-308, a CD19-targeted CD4+/CD8+ CAR-iT cell therapy engineered with Allo-Evasion 5.0 as a potential treatment for B-cell-mediated autoim...